MHRA approves deuruxolitinib to treat severe alopecia…
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults.
Read moreDetailsThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults.
Read moreDetailsHM Land Registry has published a new practice guide to help conveyancers and the wider property market understand and prepare for new requirements on contractual control agreements.
Read moreDetailsDBS has launched Series 3 of its podcast, DBS Discussions. Six new episodes explain how and when people are barred from working with children or vulnerable adults.
Read moreDetailsBenefits cheats have been put on notice with tough new anti-fraud measures used for the first time as part of a drive to save billions of pounds for the taxpayer.
Read moreDetailsThe crackdown on cosmetic cowboys intensifies this week as the government announces new restrictions on cosmetic procedures, including liquid Brazilian butt lifts (BBLs), vampire facials and chemical peels, to qualified healthcare experts only.
Read moreDetailsTribunals to use a new, stricter, approach for dismissal cases involving pregnant women and new parents from 2027
Read moreDetailsThe UK and Turkey made progress in Round 6 talks on an enhanced FTA, advancing discussions across key sectors to boost growth and opportunities. Both sides will work constructively towards the seventh round of negotiations in the coming months.
Read moreDetailsMarket comment on behalf of Zaheer Anwari – Founder of The Revacy Fund
Read moreDetails